We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+10.28%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$5.07B
AUM Growth
-$11.6M
Cap. Flow
-$144M
Cap. Flow %
-2.83%
Top 10 Hldgs %
24.83%
Holding
159
New
22
Increased
53
Reduced
27
Closed
17

Top Buys

Rank Stock Value
1
EVH icon
Evolent Health
EVH
+$48.3M
2
FLYW icon
Flywire
FLYW
+$47.9M
3
DLO icon
dLocal
DLO
+$36.1M
4
DV icon
DoubleVerify
DV
+$35.7M
5
SGEN
Seagen Inc. Common Stock
SGEN
+$31.3M

Top Sells

Rank Stock Value
1
CTAS icon
Cintas
CTAS
+$108M
2
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
+$106M
3
BHVN icon
Biohaven
BHVN
+$74.9M
4
KNBE
KnowBe4, Inc. Class A Common Stock
KNBE
+$68M
5
MDB icon
MongoDB
MDB
+$57.4M

Sector Composition

Rank Sector Weight
1 Healthcare 43.02%
2 Technology 23.53%
3 Industrials 12.87%
4 Consumer Discretionary 5.44%
5 Utilities 4.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RGEN icon
76
Repligen
RGEN
$7.03B
$20.1M 0.4%
119,000
– –
ISRG icon
77
Intuitive Surgical
ISRG
$126B
$19.9M 0.39%
75,000
– –
BPMC
78
DELISTED
Blueprint Medicines
BPMC
$19.2M 0.38%
438,500
– –
KLAC icon
79
KLA
KLAC
$236B
$19.1M 0.38%
505,620
-32,710
-6% -$1.14M
ANNX icon
80
Annexon
ANNX
$863M
$18.7M 0.37%
3,626,508
– –
ESI icon
81
Element Solutions
ESI
$8.68B
$17.7M 0.35%
971,000
– –
APLS
82
DELISTED
Apellis Pharmaceuticals
APLS
$17.5M 0.35%
339,355
– –
AESC
83
DELISTED
The AES Corporation
AESC
$17.5M 0.34%
171,200
– –
VCYT icon
84
Veracyte
VCYT
$4.77B
$17.4M 0.34%
732,000
– –
AJG icon
85
Arthur J. Gallagher & Co
AJG
$65.9B
$17.4M 0.34%
92,082
+58,150
+171% +$10.9M
NOVT icon
86
Novanta
NOVT
$4.95B
$17.1M 0.34%
125,900
– –
MASS icon
87
908 Devices
MASS
$313M
$17M 0.34%
2,230,665
+514,864
+30% +$6.23M
WEC icon
88
WEC Energy
WEC
$35.8B
$16.9M 0.33%
180,192
-23,208
-11% -$2.14M
RARE icon
89
Ultragenyx Pharmaceutical
RARE
$2.56B
$16.6M 0.33%
359,000
+53,200
+17% +$2.09M
FRC
90
DELISTED
First Republic Bank
FRC
$16.1M 0.32%
132,371
+356
+0.3% +$43.4K
NBIX icon
91
Neurocrine Biosciences
NBIX
$18.7B
$16.1M 0.32%
135,000
-100,000
-43% -$11.7M
IEX icon
92
IDEX
IEX
$17.3B
$15.8M 0.31%
69,157
+10,757
+18% +$2.4M
PNR icon
93
Pentair
PNR
$10.6B
$15.8M 0.31%
350,400
– –
INSM icon
94
Insmed
INSM
$22B
$14M 0.28%
+698,413
New +$13.5M
BRKR icon
95
Bruker
BRKR
$9.79B
$13.8M 0.27%
+202,006
New +$12.8M
SYY icon
96
Sysco
SYY
$40.6B
$13.5M 0.27%
177,100
– –
ROIV icon
97
Roivant Sciences
ROIV
$24.8B
$13.5M 0.27%
1,690,300
– –
SHW icon
98
Sherwin-Williams
SHW
$83.7B
$12.7M 0.25%
53,447
+34,755
+186% +$8.04M
MRNS
99
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$12.5M 0.25%
+3,150,000
New +$15.5M
CMS icon
100
CMS Energy
CMS
$22.7B
$12.4M 0.24%
195,500
-46,658
-19% -$2.76M
2 3
4
5 6

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q4 2022 Portfolio in Review

As of Q4 2022, Eventide Asset Management held 159 positions worth $5.07B, down 0.23% from $5.08B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Eventide Asset Management's Q4 2022 filing shows 22 new, 53 increased, 27 reduced and 17 closed positions. Its largest new stake was Seagen Inc. Common Stock: 242,545 shares worth $31.2M. The largest sale was Cintas, an estimated $108M.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, up from 39% a quarter earlier, followed by Technology and Industrials.

  • Eventide Asset Management's largest Q4 2022 buy was Seagen Inc. Common Stock: 242,545 shares worth $31.2M.
  • Eventide Asset Management added most to Evolent Health in Q4 2022, an estimated $48.3M increase.
  • Eventide Asset Management's biggest Q4 2022 reduction was Prometheus Biosciences, Inc. Common Stock, cutting an estimated $106M.
  • Eventide Asset Management fully exited Cintas in Q4 2022, selling an estimated $108M.
  • Eventide Asset Management's ten largest holdings make up 25% of its $5.07B portfolio in Q4 2022.
  • Eventide Asset Management opened 22 new positions and closed 17 in Q4 2022.
  • Eventide Asset Management's portfolio value fell 0.23% quarter-over-quarter to $5.07B.

Based on Eventide Asset Management's 13F filing for Q4 2022, filed 13 Feb 2023.